Biochemical effects in women following one year's exposure to a new triphasic contraceptive—I. chemistry profiles
- 1 March 1996
- journal article
- clinical trial
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 27 (2) , 367-370
- https://doi.org/10.1016/0306-3623(95)00099-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham StudyAmerican Heart Journal, 1987
- Oral contraceptivesPostgraduate Medicine, 1987
- The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young womenContraception, 1987
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- Cardiovascular risk status and oral contraceptive use: United States, 1976–1980Preventive Medicine, 1986
- Triphasic oral contraception: Metabolic effects in normal women and those with previous gestational diabetesAmerican Journal of Obstetrics and Gynecology, 1985
- A randomized crossover comparison of two low-dose contraceptives: Effects on serum lipids and lipoproteinsAmerican Journal of Obstetrics and Gynecology, 1985
- Relative potency of progestins used in oral contraceptivesContraception, 1985
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981